High-Throughput, High-Resolution Interferometric Light Microscopy of Biological Nanoparticles

ACS Nano. 2020 Feb 25;14(2):2002-2013. doi: 10.1021/acsnano.9b08512. Epub 2020 Feb 12.

Abstract

Label-free, visible light microscopy is an indispensable tool for studying biological nanoparticles (BNPs). However, conventional imaging techniques have two major challenges: (i) weak contrast due to low-refractive-index difference with the surrounding medium and exceptionally small size and (ii) limited spatial resolution. Advances in interferometric microscopy have overcome the weak contrast limitation and enabled direct detection of BNPs, yet lateral resolution remains as a challenge in studying BNP morphology. Here, we introduce a wide-field interferometric microscopy technique augmented by computational imaging to demonstrate a 2-fold lateral resolution improvement over a large field-of-view (>100 × 100 μm2), enabling simultaneous imaging of more than 104 BNPs at a resolution of ∼150 nm without any labels or sample preparation. We present a rigorous vectorial-optics-based forward model establishing the relationship between the intensity images captured under partially coherent asymmetric illumination and the complex permittivity distribution of nanoparticles. We demonstrate high-throughput morphological visualization of a diverse population of Ebola virus-like particles and a structurally distinct Ebola vaccine candidate. Our approach offers a low-cost and robust label-free imaging platform for high-throughput and high-resolution characterization of a broad size range of BNPs.

Keywords: Fourier optics; biosensing; computational imaging; interference microscopy; label-free; nanoparticle detection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ebola Vaccines / chemistry*
  • High-Throughput Screening Assays*
  • Microscopy, Interference*
  • Nanoparticles / chemistry*
  • Particle Size
  • Surface Properties
  • Viral Proteins / chemistry*

Substances

  • Ebola Vaccines
  • Viral Proteins